Early Aortic vaLve surgEry Versus wAtchful waitiNg Strategy in Severe Asymptomatic aOrtic reguRgitation

Recruiting N/A Interventional Study
Aortic Valve Regurgitation
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
217 (estimated)
Sponsor
Na Homolce Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The optimal timing of surgical intervention in asymptomatic patients with severe aortic regurgitation remains controversial. As per cardiac magnetic resonance assessment, early surgical treatment will be compared with conventional guideline-based strategy in asymptomatic patients with severe aortic regurgitation.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Chronic asymptomatic aortic regurgitation grade 3 (moderate to severe) and grade 4 (severe) * No indication for the surgical treatment at the time of enrolment * LV ejection fraction \>50% * Absence of more than mild-to-moderate concomitant valve disease or complex congenital …
Contacts

Radka Kočková, MD,PhD

+420606483586

radka.kockova@centrum.cz

CONTACT

Jan Vojáček, MD, PhD

+420777095921

jan.vojacek1@fnhk.cz

CONTACT